Douglas Williams, PA
Medical · Kailua, HINPI 1033384011
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.4% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 30.1% of the total.
Across 281 payments — averaging $28.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Regeneron Healthcare Solutions, Inc.$2K
- Sanofi$847
- Lilly USA, LLC$764
- LEO Pharma Inc.$505
- UCB, Inc.$423
- plus $2K from 14 others
What the payments were for
- Travel & lodging$2663%
- Food & beverage$7,76095%
- Education$1091%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 91 | $2,446 |
| Regeneron Healthcare Solutions, Inc. | 34 | $1,592 |
| Sanofi | 28 | $847 |
| Lilly USA, LLC | 33 | $764 |
| LEO Pharma Inc. | 29 | $505 |
| UCB, Inc. | 15 | $423 |
| Atricure, Inc. | 2 | $359 |
| Pfizer | 9 | $220 |
| Novartis | 9 | $173 |
| Galderma Laboratories, L.p. | 7 | $158 |
| E.r. Squibb & Sons, L.L.C. | 2 | $108 |
| Arcutis Biotherapeutics, Inc. | 4 | $103 |
| Revance Therapeutics, Inc. | 3 | $94 |
| Incyte Corporation | 4 | $82 |
| Organon | 3 | $75 |
| Sun Pharmaceutical Industries Inc. | 1 | $65 |
| Biofrontera Inc. | 4 | $62 |
| Organogenesis Inc. | 1 | $22 |
| Mimedx Group, Inc. | 1 | $21 |
| Merz North America, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$875
- Rinvoq$355
- SYNERGY ABLATION SYSTEM$266
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$266
- Bimzelx$125
- ADBRY$125
How this compares
$8,136 in reported general payments places this provider in the 85th percentile of 63 medical providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 14 | $52,230 |
| Cephalexin | 36 | $2,302 |
| Clobetasol Propionate | 23 | $1,889 |
| Ciprofloxacin Hcl | 27 | $1,257 |
| Fluorouracil | 19 | $1,230 |
| Hydrocortisone | 51 | $935 |
| Triamcinolone Acetonide | 59 | $914 |
| Liothyronine Sodium | 34 | $864 |
| Metronidazole | 23 | $862 |
| SsdSilver Sulfadiazine | 72 | $849 |
| Hydroxychloroquine Sulfate | 11 | $848 |
| Pentoxifylline | 45 | $825 |
| Fluocinonide | 16 | $561 |
| Ketoconazole | 32 | $543 |
| Halobetasol Propionate | 13 | $483 |
Paid to pharmacies, not to this prescriber.
Other medical in Kailua
- Sarah BeatonKailua$10K
- Annina KingKailua$6K
- Christina RobbinsKailua$6K
- Leslie HuddlestonKailua$41
- Lisa AdamsHonolulu$189K
- Susan StewartWailuku$47K
- Leena HongHonolulu$30K
- Jeanelle AhunaHonolulu$16K
- Justin MaioHonolulu$12K
- Darren GeligaKailua Kona$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.